The Interconnection Between Pharmaceutical Development and Preclinical Research (Review)
Introduction. Pharmaceutical development of an innovative highly effective and competitive drug is a long and expensive process, the result of which is quite difficult to predict in advance. To speed up the entry of a new drug to the treatment and reduce the developer's material costs, it is ad...
Saved in:
Main Authors: | I. N. Ampilogova, M. V. Karlina, V. G. Makarov, M. N. Makarova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-05-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/1495 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmaceutical Toxicology is the Most Important Component of Preclinical Studies
by: A. D. Durnev
Published: (2023-03-01) -
Endocrine Disorders Associated with Medicinal Products: Approaches to Preclinical Safety Assessment
by: K. L. Kryshen, et al.
Published: (2023-03-01) -
ANALYTICAL REVIEW OF THE NORMATIVE BASE TO PROVIDE THE GOOD QUALITY OF PRECLINICAL STUDIES IN RUSSIA
by: A. I. Selezneva, et al.
Published: (2019-01-01) -
Preclinical Studies in the Pharmaceutical Development Cycle
by: M. N. Makarova
Published: (2024-07-01) -
The Modern Concepts of Pharmaceutical Development in the Context of the Transition to a Uniform Regulation of Medicinal Products Circulation
by: A. E. Feofilova, et al.
Published: (2020-11-01)